Title: Progressive supranuclear palsy: Postmortem chemical analysis
Abstract: Annals of NeurologyVolume 18, Issue 5 p. 521-522 Editorial Progressive supranuclear palsy: Postmortem chemical analysis Anne B. Young MD, PhD, Anne B. Young MD, PhD Department of Neurology University of Michigan Ann Arbor, MI 48104Search for more papers by this author Anne B. Young MD, PhD, Anne B. Young MD, PhD Department of Neurology University of Michigan Ann Arbor, MI 48104Search for more papers by this author First published: November 1985 https://doi.org/10.1002/ana.410180502Citations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Jankovic J: Progressive supranuclear palsy: clinical and pharmacologic update. Neurol Clin 2: 473– 486, 1984 2 Steele JC: Progressive supranuclear palsy. Brain 95: 693– 704, 1972 3 Steele JC, Richardson JC, Olszewski J: Progressive supranuclear palsy: a heterogenous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10: 333– 359, 1964 4 Tagliavini F, Pilleri G, Bouras C, Constantinidis J: The basal nucleus of Meynert in patients with progressive supranuclear palsy. Neurosci Lett 44: 37– 42, 1984 Citing Literature Volume18, Issue5November 1985Pages 521-522 ReferencesRelatedInformation